Opioid Use May Contribute to Risk for Pancreatic Cancer
FRIDAY, Jan. 22, 2021 -- Opioid use seems to contribute to the increasing incidence of pancreatic cancer (PC) in the United States, according to a study published online Jan. 6 in PLOS ONE.
Usman Barlass, M.D., from Rush University Medical Center in Chicago, and colleagues examined whether opioid usage patterns over time could explain state- and national-based variations in PC rates in the United States using national databases. They assessed the association between levels of PC rate and opioid death/use rates during 1999 to 2016.
The researchers identified an increase in PC over time at the national and state levels. Over time, increases were also seen in opioid death rates. Of the potential PC risk factors, during the study period, only obesity prevalence increased. The initial incidence of PC was significantly predicted by a state's opioid death rate at four years prior (ß = 0.1848), which also had a significant effect on the estimated annual change in PC rate (ß = −0.0193).
"Our analysis of state-based databases suggests that opioid usage pattern may explain the trend of increased pancreatic cancer over time," the authors write. "[The finding of] opioids as a novel risk factor [for] pancreatic cancer needs to be confirmed in population-based studies."
© 2021 HealthDay. All rights reserved.
Posted: January 2021
Read this next
MONDAY, March 1, 2021 -- Youth with prescription opioid misuse (POM), especially current POM, have an increased risk for suicide-related behaviors, according to a study published...
THURSDAY, Feb. 25, 2021 -- The total lifetime opioid-related costs generated by symptomatic knee osteoarthritis (SKOA) in the United States are $14.0 billion, about half of which...
TUESDAY, Feb. 23, 2021 -- A text message system can monitor postoperative opioid use and shows that many prescribed opioid tablets are unused, according to a case study published...
More News Resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our Newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.